Literature DB >> 3941763

Dietary treatment of adrenoleukodystrophy.

S Suzuki, T Kobayashi, I Goto, Y Kuroiwa.   

Abstract

We treated two patients with adrenoleukodystrophy (ALD) with a diet that contained 0.636% lipids as soybean oil, and less than 0.01% of the total fatty acids were very-long-chain fatty acids (VLCFA). Although clinical improvement was not evident in either patient, the VLCFA levels of erythrocyte membranes and plasma decreased in patient 1; in particular, the C25:0 in erythrocyte membranes became normal. Therefore, the abnormal accumulation of VLCFA in ALD arises partially from the diet. The VLCFA-free diet should be beneficial in ALD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941763     DOI: 10.1212/wnl.36.1.104

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Glycerol trioleate/glycerol trierucate therapy in X-linked adrenoleukodystrophy: saturated and unsaturated fatty acids in blood cells. Implications for the follow-up.

Authors:  M Ruiz; T Pampols; M Girós
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Peroxisomal disorders: clinical characterization.

Authors:  L Monnens; H Heymans
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.

Authors:  S Zierz; R Schröder; C J Unkrig
Journal:  Clin Investig       Date:  1993-10

4.  Familial spinocerebellar degeneration as an expression of adrenoleukodystrophy.

Authors:  T Kobayashi; S Noda; H Umezaki; I Goto; S Suzuki; T Kitaguchi; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.